Fresenius Medical Care AG & Co. KGaA

FMS Healthcare Medical Care Facilities

Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024.

Revenue
−0.49%
EPS
−10.6%
Free cash flow
−3.47%
Total debt
+8.09%

Quarter to September 2026, against a year earlier

23.66 0.47 +2.03%
Market cap
$12.6B
P/E
12.6×
Fwd P/E
14.4×
Dividend yield
3.68%
F-score
8/9
Altman Z
1.88
Beneish M
−2.77
Dividend safety
42/100

Fresenius Medical Care AG & Co. KGaA (FMS) EBITDA

Alert me on EBITDA

Fresenius Medical Care AG & Co. KGaA's EBITDA for fiscal 2025 was $3.8B, up 11.0% from $3.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.8B. Over the past ten years it has ranged from $3.0B (fiscal 2015) to $4.7B (fiscal 2020); the current reading is higher than 64% of that period. Fresenius Medical Care AG & Co. KGaA ranks 3rd of 48 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $3.8B 10.99%
FY2024 $3.4B 0.41%
FY2023 $3.4B (4.29%)
FY2022 $3.5B (14.17%)
FY2021 $4.1B (11.98%)
FY2020 $4.7B 8.00%
FY2019 $4.3B (2.64%)
FY2018 $4.4B 26.91%
FY2017 $3.5B 2.58%
FY2016 $3.4B 12.14%

Quarterly newest first

Period EBITDA Change
Sep 2026 $930.8M (3.07%)
Jun 2026 $960.3M 9.52%
Mar 2026 $876.8M (17.17%)
Dec 2025 $1.1B 5.81%
43 more quarters

Against its own ten years

Low $3.0B High $4.7B
Ten-year median $3.5B
Current reading's percentile 64

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on FMS